These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116 [TBL] [Abstract][Full Text] [Related]
4. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Quinn N Neurology; 2001 Aug; 57(4):746-7. PubMed ID: 11524505 [No Abstract] [Full Text] [Related]
5. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. 2000. Parkinson Study Group Neurology; 2001 Nov; 57(10 Suppl 3):S52-9. PubMed ID: 11775602 [No Abstract] [Full Text] [Related]
6. Dopamine transporter imaging in essential tremor with and without parkinsonian features. Waln O; Wu Y; Perlman R; Wendt J; Van AK; Jankovic J J Neural Transm (Vienna); 2015 Nov; 122(11):1515-21. PubMed ID: 26133163 [TBL] [Abstract][Full Text] [Related]
7. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses. Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771 [TBL] [Abstract][Full Text] [Related]
8. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography. Im JH; Chung SJ; Kim JS; Lee MC J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371 [TBL] [Abstract][Full Text] [Related]
9. PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease. Ilgin N; Zubieta J; Reich SG; Dannals RF; Ravert HT; Frost JJ Neurology; 1999 Apr; 52(6):1221-6. PubMed ID: 10214747 [TBL] [Abstract][Full Text] [Related]
10. [Dopamine transporter SPECT in patients with Parkinson's disease]. Hamano T; Tsuchida T; Hirayama M; Fujiyama J; Mutoh T; Yonekura Y; Kuriyama M Kaku Igaku; 2000 Mar; 37(2):125-9. PubMed ID: 10783572 [TBL] [Abstract][Full Text] [Related]
11. A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders. Goebel G; Seppi K; Donnemiller E; Warwitz B; Wenning GK; Virgolini I; Poewe W; Scherfler C Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):702-10. PubMed ID: 21174092 [TBL] [Abstract][Full Text] [Related]
12. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060 [TBL] [Abstract][Full Text] [Related]
13. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study. Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438 [TBL] [Abstract][Full Text] [Related]
15. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Pirker W Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Extrastriatal Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628 [No Abstract] [Full Text] [Related]
17. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice. Poewe W; Scherfler C Mov Disord; 2003 Oct; 18 Suppl 7():S16-21. PubMed ID: 14531041 [TBL] [Abstract][Full Text] [Related]
18. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779 [TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849 [TBL] [Abstract][Full Text] [Related]
20. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]